Last Updated: 16/02/2024
Alpha-PBO LLIN Phase II Support
Objectives
To produce Phase II data for evaluation of a new alphacypermethrin-PBO LLIN
External reference
Thematic Categories
Date
Oct 2020 — Sep 2022
Total Project Funding
$100,217
Funding Details
Gates Foundation (GF), United States
INV-023420
Project Site
Related Resources
